breakout?, page-61

Patrys ASX and media release 06/11/13
It also presents a unique opportunity for Patrys to fast track the development of the PATSM6 product in both the USA and Europe.

http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm

Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review Expediting Availability of New Drugs for Patients with Serious Conditions

Also this might be nice

http://www.fda.gov/forconsumers/consumerupdates/ucm107293.htm

Waiver of Prescription Drug User Fee Act (PDUFA) filing fees (over $1,000,000 per application for FY 2009)